Ayala Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q4 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Ayala Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from Q4 2010 to Q1 2023.
  • Ayala Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $44K, a 46.7% increase year-over-year.
  • Ayala Pharmaceuticals, Inc. annual Depreciation for 2023 was $334K, a 106% increase from 2022.
  • Ayala Pharmaceuticals, Inc. annual Depreciation for 2022 was $162K, a 58.1% decline from 2021.
  • Ayala Pharmaceuticals, Inc. annual Depreciation for 2021 was $387K, a 56.9% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $44K +$14K +46.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-23
Q2 2022 $82K $13K -$37K -74% May 1, 2022 Jul 31, 2022 10-Q 2022-09-13
Q1 2022 $119K $30K -$94K -75.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-23
Q4 2021 $213K $18K -$174K -90.6% Nov 1, 2021 Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $387K $21K -$247K -92.2% Aug 1, 2021 Oct 31, 2021 10-K 2023-02-10
Q2 2021 $634K $50K -$150K -75% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 $784K $124K -$76K -38% Feb 1, 2021 Apr 30, 2021 10-Q 2022-06-08
Q4 2020 $860K $192K -$37K -16.2% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-17
Q3 2020 $897K $268K +$56K +26.4% Aug 1, 2020 Oct 31, 2020 10-K 2022-02-14
Q2 2020 $841K $200K -$100K -33.3% May 1, 2020 Jul 31, 2020 10-Q 2021-09-10
Q1 2020 $941K $200K -$100K -33.3% Feb 1, 2020 Apr 30, 2020 10-Q 2021-06-14
Q4 2019 $1.04M $229K -$56K -19.6% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-16
Q3 2019 $1.1M $212K -$36K -14.5% Aug 1, 2019 Oct 31, 2019 10-K 2021-01-22
Q2 2019 $1.13M $300K $0 0% May 1, 2019 Jul 31, 2019 10-Q 2020-09-10
Q1 2019 $1.13M $300K $0 0% Feb 1, 2019 Apr 30, 2019 10-Q 2020-06-11
Q4 2018 $1.13M $285K +$20K +7.55% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-13
Q3 2018 $1.11M $248K -$5.6K -2.21% Aug 1, 2018 Oct 31, 2018 10-K 2019-12-20
Q2 2018 $1.12M $300K +$100K +50% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 $1.02M $300K +$120K +66.8% Feb 1, 2018 Apr 30, 2018 10-Q 2019-06-10
Q4 2017 $898K $265K +$107K +68.2% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-12
Q3 2017 $791K $254K +$134K +111% Aug 1, 2017 Oct 31, 2017 10-K 2019-01-11
Q2 2017 $657K $200K +$132K +192% May 1, 2017 Jul 31, 2017 10-Q 2018-09-10
Q1 2017 $526K $180K +$131K +266% Feb 1, 2017 Apr 30, 2017 10-Q 2018-06-07
Q4 2016 $395K $158K +$112K +242% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-12
Q3 2016 $284K $120K +$89.3K +291% Aug 1, 2016 Oct 31, 2016 10-K 2017-12-21
Q2 2016 $194K $68.5K +$54.3K +382% May 1, 2016 Jul 31, 2016 10-Q 2017-09-11
Q1 2016 $140K $49.1K +$41.8K +577% Feb 1, 2016 Apr 30, 2016 10-Q 2017-06-06
Q4 2015 $98.2K $46K +$39.1K +567% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-10
Q3 2015 $59K $30.7K +$23.8K +345% Aug 1, 2015 Oct 31, 2015 10-K 2017-12-21
Q2 2015 $35.3K $14.2K +$7.3K +106% May 1, 2015 Jul 31, 2015 10-Q 2016-09-08
Q1 2015 $28K $7.25K +$343 +4.97% Feb 1, 2015 Apr 30, 2015 10-Q 2016-06-08
Q4 2014 $27.6K $6.9K -$1 -0.01% Nov 1, 2014 Jan 31, 2015 10-Q 2016-02-26
Q3 2014 $27.6K $6.9K +$1.23K +21.7% Aug 1, 2014 Oct 31, 2014 10-K 2017-01-09
Q2 2014 $26.4K $6.9K +$2.46K +55.4% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 $23.9K $6.9K +$2.31K +50.3% Feb 1, 2014 Apr 30, 2014 10-Q 2015-06-15
Q4 2013 $21.6K $6.9K +$2.31K +50.3% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-13
Q3 2013 $19.3K $5.67K +$1.08K +23.5% Aug 1, 2013 Oct 31, 2013 10-K 2015-01-06
Q2 2013 $18.2K $4.44K -$150 -3.27% May 1, 2013 Jul 31, 2013 10-Q 2014-09-09
Q1 2013 $18.4K $4.59K $0 0% Feb 1, 2013 Apr 30, 2013 10-Q 2014-06-10
Q4 2012 $18.4K $4.59K +$4.59K Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-17
Q3 2012 $13.8K $4.59K Aug 1, 2012 Oct 31, 2012 10-K 2014-01-29
Q2 2012 $4.59K May 1, 2012 Jul 31, 2012 10-Q 2013-09-16
Q1 2012 $4.59K Feb 1, 2012 Apr 30, 2012 10-Q 2013-06-14
Q4 2011 $0 -$9.78K -100% Nov 1, 2011 Jan 31, 2012 10-Q/A 2013-03-25
Q4 2010 $9.78K Nov 1, 2010 Jan 31, 2011 10-Q/A 2012-10-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.